SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venky's (India) gains on starting commercial production of Veterinary Medicine Products at Satara unit

20 Mar 2024 Evaluate

Venky'S (India) is currently trading at Rs. 1606.30, up by 24.65 points or 1.56% from its previous closing of Rs. 1581.65 on the BSE.

The scrip opened at Rs. 1612.10 and has touched a high and low of Rs. 1638.65 and Rs. 1586.30 respectively. So far 8128 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2312.95 on 07-Aug-2023 and a 52 week low of Rs. 1420.10 on 29-Mar-2023.

Last one week high and low of the scrip stood at Rs. 1658.30 and Rs. 1575.80 respectively. The current market cap of the company is Rs. 2259.47 crore.

The promoters holding in the company stood at 56.11%, while Institutions and Non-Institutions held 1.19% and 42.70% respectively.

Venky's (India) has started commercial production of Veterinary Medicine Products under its Animal Health Product Segment at Village Kesurdi, Taluka Satara, Maharashtra. This project is to manufacture Veterinary Medicines Powders (600 Tonnes/Annum) and Veterinary Medicines Liquids (300 Kilolitres / Annum) to cater the growing demand from poultry industry.

Venky’s (India) was established in 1976, mainly to produce day-old layer and broiler chicks for the dense poultry markets of North India.

Venkys India Share Price

1582.75 -6.50 (-0.41%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1582.75
Mangalam Global Ent 14.12
Kaveri Seed 933.00
Regaal Resources 83.14
Simran Farms 168.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×